TP53共同突变增加了EGFR突变的I期肺腺癌复发的风险
Filippo Tommaso Gallina1, Daniele Marinelli2, Riccardo Tajè3
1Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC, Canada; Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy; Tumor Immunology and Immunotherapy Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
对于具有EGFR突变的早期肺腺癌 (LUAD),同时发生的TP53突变表明无复发生存率 (RFS) 更差. 这突显了切除的LUAD中EGFR/TP53共变的攻击性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 辅助性奥西梅丁尼改善了切除EGFR突变NSCLC (非小细胞肺癌) 的生存率.
- 在切除的I期瘤中同时发生突变的预后影响仍然不清楚.
- EGFR/TP53共同突变与晚期NSCLC的预后不佳有关.
研究的目的:
- 研究EGFR/TP53共变的预后意义.
- 专注于未经治疗的,切除的I期肺腺癌 (LUAD).
- 评估对无复发性生存率 (RFS) 的影响.
主要方法:
- 从两个中心的I阶段LUAD患者的回顾性分析.
- 对突变进行分子测试 (EGFR,TP53).
- 使用卡普兰-梅尔和考克斯回归的生存分析;在公共数据集中验证.
主要成果:
- 分析了370名患者;97人患有EGFR突变.
- 在初级队列中,EGFR/TP53共同突变显著与更糟糕的RFS相关 (p=0.001).
- 外部验证证实与较短的RFS和相似的整体存活率 (OS) 有关.
结论:
- 在EGFR突变的切除I阶段LUAD中TP53共变异预测了更糟糕的RFS.
- 这些发现支持EGFR/TP53共变的侵略性生物学.
- 突出了 LUAD 早期风险分层的潜力.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
相关概念视频
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
